更正：m6a介导的lncRNA BLACAT3上调通过YBX3核穿梭和增强NCF2转录促进膀胱癌血管生成和血液转移。

IF 7.3 1区医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

Oncogene Pub Date : 2025-09-17 DOI:10.1038/s41388-025-03575-x

Jinbo Xie, Hui Zhang, Keyi Wang, Jinliang Ni, Xiaoying Ma, Christopher J. Khoury, Viktor Prifti, Brock Hoard, Eric G. Cerenzia, Lei Yin, Houliang Zhang, Ruiliang Wang, Dong Zhuo, Weipu Mao, Bo Peng

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Correction: M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription

查看原文本刊更多论文

Correction: M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Oncogene 医学-生化与分子生物学

CiteScore

15.30

自引率

1.20%

发文量

404

审稿时长

1 months

期刊介绍： Oncogene is dedicated to advancing our understanding of cancer processes through the publication of exceptional research. The journal seeks to disseminate work that challenges conventional theories and contributes to establishing new paradigms in the etio-pathogenesis, diagnosis, treatment, or prevention of cancers. Emphasis is placed on research shedding light on processes driving metastatic spread and providing crucial insights into cancer biology beyond existing knowledge. Areas covered include the cellular and molecular biology of cancer, resistance to cancer therapies, and the development of improved approaches to enhance survival. Oncogene spans the spectrum of cancer biology, from fundamental and theoretical work to translational, applied, and clinical research, including early and late Phase clinical trials, particularly those with biologic and translational endpoints.